Trazodone for Dogs: Situational Anxiety and Post-Op Confinement Dosing

Bottom line

Trazodone is a serotonin antagonist/reuptake inhibitor (SARI) that has become a first-reach agent for canine situational anxiety and, especially, for making post-operative cage rest tolerable. All canine use is off-label; there is no veterinary-labeled product [1]. Reach for it when you need a relatively fast, single-event anxiolytic (onset roughly 1–2 hours) or an adjunct to layer onto a daily SSRI/TCA for breakthrough anxiety. Common dosing sits around 2–7.5 mg/kg PO q8–24h, titrated to effect, not to exceed ~19.5 mg/kg in any 24-hour period [1]. The dominant safety concern is serotonin syndrome when combined with other serotonergic drugs (fluoxetine, TCAs, tramadol, MAOIs including selegiline and amitraz) [2].

Drug facts

• Class: Serotonin antagonist and reuptake inhibitor (SARI); an atypical antidepressant/anxiolytic [3].
• Mechanism: At the low-to-moderate doses used clinically, trazodone antagonizes postsynaptic 5-HT2A receptors and inhibits serotonin reuptake, with additional H1-histaminergic and alpha-1-adrenergic antagonism that drives the sedation and mild hypotensive effect [3]. At high doses the serotonergic agonism predominates, which is the mechanistic basis for serotonin syndrome [2].
• Regulatory status: Off-label / extralabel in all species — no products are labeled for veterinary use; prescribing relies on repurposed human formulations [2].
• Formulations: Human immediate-release tablets (commonly 50, 100, 150, 300 mg), plus extended-release products; immediate-release is the workhorse for both situational and post-op use [2].

Indications

• Situational / event anxiety: Discrete, predictable stressors — veterinary visits, travel, thunderstorms, and fireworks — where a single pre-event dose is the goal. Trazodone's onset is fast enough for same-day use, unlike SSRIs that need weeks to reach effect.
• Post-operative confinement and hospitalization stress: The best-supported niche. In an open-label trial of dogs recovering from orthopedic surgery, 89% (32/36) of owners rated their dog moderately or extremely improved in confinement tolerance and calmness over the recovery period, and the drug was well tolerated alongside NSAIDs, antimicrobials, and other post-op medications [4]. This makes trazodone a practical tool for enforcing strict cage rest.
• Adjunct to a daily anxiolytic: Layered onto an SSRI or TCA for breakthrough or situational anxiety. The original case series that put trazodone on the map was exactly this use — an adjunctive agent in dogs with anxiety disorders, well tolerated over a wide dose range and enhancing behavioral calming on daily or as-needed dosing [5].

Dosing

Doses below are off-label and should be titrated to the individual patient. Start low and work up.

• General range (Merck): 2–7.5 mg/kg PO q8–24h as needed, not exceeding ~19.5 mg/kg in any 24-hour period [1].
• Situational / single-event use: Give one dose ahead of the anticipated stressor; timing 1–2 hours before the event aligns with the onset window [3]. Many clinicians trial the dose on a low-stress day first to confirm tolerability and gauge sedation before relying on it for the real event.
• Ongoing / post-op confinement: The published orthopedic-recovery protocol started at ~3.5 mg/kg PO q12h beginning the day after surgery, increased after ~3 days to ~7 mg/kg PO q12h, with the option to escalate to ~7–10 mg/kg PO q8h if needed [4]. The original adjunctive case series similarly reported tolerability across a wide dose range on daily or as-needed dosing [5]; the practical takeaway from both is to titrate to effect rather than commit to a fixed dose.

Onset & what to tell the owner

Onset is relatively rapid: in the post-surgical trial, owner-reported median onset was 31–45 minutes with a median duration of effect of ≥ 4 hours [4]; clinically, effect is generally seen within about 1–2 hours of an oral dose [3]. Counsel owners to: dose ahead of the trigger rather than after anxiety has already peaked; expect sedation and possible wobbliness; do a trial dose before a high-stakes event; and contact you if they see agitation or restlessness rather than calming (paradoxical excitation), which warrants re-evaluation.

Adverse effects

Generally well tolerated [4]. Watch for:

• Sedation, lethargy, and ataxia — the most common, dose-related effects [2].
• GI upset (vomiting, diarrhea) and appetite changes [2].
• Panting and hypotension, more likely at higher doses [2].
• Paradoxical excitation — agitation, restlessness, or increased fearfulness instead of calming [2]. Discontinue or reassess rather than pushing the dose.

Drug interactions & contraindications

The headline risk is serotonin syndrome when trazodone is combined with other serotonergic agents: SSRIs (e.g., fluoxetine), TCAs (e.g., clomipramine, amitriptyline), tramadol, metoclopramide, and MAOIs including selegiline and the amitraz found in some collars/dips [2]. Because trazodone is so often used as an adjunct to a daily SSRI or TCA, this combination is common by design — use it deliberately, start at the low end, and monitor for signs (GI upset, tremor/hyperesthesia, agitation, mydriasis, hyperthermia, seizures) [2]. Concurrent MAOI use is a contraindication [3]. Hepatic metabolism means caution in hepatic disease; the alpha-1 and H1 antagonism warrants caution in patients with cardiac disease or hypotension. Note the look-alike/sound-alike confusion between trazodone and tramadol on prescriptions — a real dispensing hazard given both are serotonergic [3].

Frequently Asked Questions